ProKidney (PROK) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free PROK Stock Alerts $2.71 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProKidney (NASDAQ:PROK) Stock Price Down 7.4%marketbeat.com - April 25 at 6:17 PMProKidney Corp. (NASDAQ:PROK) SVP Darin J. Weber Sells 16,438 Sharesamericanbankingnews.com - April 24 at 5:10 AMInsider Selling: ProKidney Corp. (NASDAQ:PROK) SVP Sells 16,438 Shares of Stockinsidertrades.com - April 24 at 5:09 AMProKidney (NASDAQ:PROK) Sees Large Volume Increasemarketbeat.com - April 22 at 1:31 PMProKidney (NASDAQ:PROK) Stock Price Down 2.5%americanbankingnews.com - April 21 at 3:12 AMPROK Apr 2024 5.000 putfinance.yahoo.com - April 20 at 5:47 PMProKidney (NASDAQ:PROK) Shares Down 2.5% marketbeat.com - April 19 at 12:24 PMDarin J. Weber Sells 17,238 Shares of ProKidney Corp. (NASDAQ:PROK) Stockinsidertrades.com - April 19 at 6:50 AMDarin J. Weber Sells 84,103 Shares of ProKidney Corp. (NASDAQ:PROK) Stockamericanbankingnews.com - April 19 at 5:38 AMProKidney (NASDAQ:PROK) Shares Gap Down After Insider Sellingamericanbankingnews.com - April 19 at 1:22 AMProKidney (NASDAQ:PROK) Shares Gap Down Following Insider Sellingmarketbeat.com - April 18 at 10:35 AMProKidney Corp. (NASDAQ:PROK) SVP Darin J. Weber Sells 17,238 Sharesmarketbeat.com - April 17 at 9:22 PMProKidney (NASDAQ:PROK) Shares Gap Up to $2.72marketbeat.com - April 17 at 10:52 AMDuring manufacturing pause, ProKidney increases R&D spending to $106.7Mbizjournals.com - March 26 at 1:12 AMProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operationsglobenewswire.com - March 25 at 6:05 AMBuy Rating Affirmed for ProKidney Amidst Strategic Clinical Advancements and Solid Financial Outlookmarkets.businessinsider.com - March 24 at 5:00 AMProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlightsglobenewswire.com - March 21 at 7:49 PMProKidney (PROK) to Release Earnings on Fridaymarketbeat.com - March 21 at 7:37 AMProKidney assumed with an Equal Weight at Morgan Stanleyrealmoney.thestreet.com - March 7 at 9:14 AMProKidney (NASDAQ:PROK) Earns Equal Weight Rating from Morgan Stanleymarketbeat.com - March 7 at 8:21 AMProKidney (PROK) Set to Announce Earnings on Mondaymarketbeat.com - March 3 at 7:31 AMProKidney to Participate in Jefferies Biotech on the Bay Summitglobenewswire.com - February 29 at 4:05 PMPROK Mar 2024 7.500 callfinance.yahoo.com - February 17 at 2:18 PMNorth Carolina biotech tops $400M in funding for asthma treatmentbizjournals.com - February 16 at 7:54 AMProKidney (NASDAQ: PROK)fool.com - February 9 at 10:28 AMSocial Capital Group LLC Sells 1,700,000 Shares of ProKidney Corp. (NASDAQ:PROK)marketbeat.com - January 10 at 11:42 AMBTIG Reaffirms Their Buy Rating on ProKidney (PROK)markets.businessinsider.com - January 3 at 12:13 AMProKidney (NASDAQ:PROK) Downgraded by Bank of Americamarketbeat.com - January 2 at 9:09 AMStories to Watch in 2024: Leadership changes, manufacturing pause make 2024 critical year for ProKidneybizjournals.com - December 28 at 7:57 PMPROK Jan 2024 10.000 callca.finance.yahoo.com - December 16 at 6:14 PMHere's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Nowfinance.yahoo.com - December 13 at 12:00 PMProKidney makes two changes to C-suite, terminating long-serving COO and promoting from within for chief business officerbizjournals.com - November 30 at 6:55 PMProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officerfinance.yahoo.com - November 30 at 8:54 AMProKidney former 10% owner Chamath Palihapitiya discloses sale of over 7M sharesmsn.com - November 21 at 4:12 PMProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conferencefinance.yahoo.com - November 21 at 8:41 AMProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 17 at 6:40 PMCompanies Like ProKidney (NASDAQ:PROK) Are In A Position To Invest In Growthfinance.yahoo.com - November 17 at 8:39 AMAfter Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)finance.yahoo.com - November 16 at 2:22 PMProKidney’s Future Promising: REACT Trial Success and Strategic Enrollment Shift Boosts Buy Ratingmarkets.businessinsider.com - November 16 at 9:22 AMProKidney pauses manufacturing after audit, company saysmsn.com - November 15 at 1:20 AMProKidney GAAP EPS of -$0.18msn.com - November 14 at 10:19 AMProKidney Reports Third Quarter Financial Resultsfinance.yahoo.com - November 14 at 10:19 AMProKidney Corp (PROK) Reports Q3 Financial Results: Focus on Chronic Kidney Disease Trialsfinance.yahoo.com - November 14 at 10:19 AMProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updatesfinance.yahoo.com - November 13 at 6:17 PM10% Owner At This Health Care Company Sells $645K of Stockbenzinga.com - November 1 at 11:46 AMProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023finance.yahoo.com - October 30 at 8:02 PMPower Player 2023: Tim Bertram, ProKidneybizjournals.com - October 23 at 8:04 AMProKidney 10% Owner Sold $1.21M In Company Stockbenzinga.com - October 20 at 2:36 PMProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Cornerfinance.yahoo.com - October 17 at 2:08 PMIs Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock?investorplace.com - October 16 at 4:07 PM Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> PROK Media Mentions By Week PROK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PROK News Sentiment▼0.470.41▲Average Medical News Sentiment PROK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PROK Articles This Week▼131▲PROK Articles Average Week Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRME News NVAX News ALLO News VALN News EXAI News HLVX News CABA News FATE News ALEC News MESO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PROK) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
